Warren Buffett Just Spent $3.9 Billion Investing in 10 Different Stocks. Here's the Best of the Bunch.

Berkshire Hathaway continued its trend of selling more stock than buying for the 11th consecutive quarter, leading its cash position to balloon to $344 billion by June. Despite this, Warren Buffett's firm deployed $3.9 billion into equities last quarter, establishing or adding to 10 positions, including UnitedHealth, Nucor, and homebuilders Lennar and D.R. Horton. Notably, Berkshire has consistently bought Constellation Brands, highlighting its strong market share in premium beer, significant free cash flow generation, and attractive valuation as a compelling long-term value investment.

Analysis

Berkshire Hathaway's recent 13F filing reveals a continued cautious stance on equity markets, marked by 11 consecutive quarters of being a net seller and a subsequent cash position expansion to $344 billion. This signals a perceived lack of broad market value by its management. However, the firm selectively deployed $3.9 billion into ten stocks, indicating that specific opportunities persist. Among the notable additions, the purchase of UnitedHealth (UNH) represents a classic contrarian investment, targeting a company facing poor financial results, negative sentiment, and a Medicare fraud investigation. The investment in Nucor (NUE) appears to be a thematic play on the buildout of AI-related data centers, further supported by potential pricing power from a 50% tariff on steel imports. Investments in homebuilders Lennar (LEN) and D.R. Horton (DHI) are positioned against near-term headwinds of high interest rates but are underpinned by a long-term structural housing shortage. The most emphasized position is Constellation Brands (STZ), which Berkshire has purchased for three straight quarters. The thesis for STZ is built on its dominant market share in the premium beer category, consistent free cash flow generation projected at $1.5-$1.6 billion annually, and a commitment to capital returns through buybacks and dividends, all at a valuation of less than 13 times forward earnings.

Key Decisions for Investors

• Given Berkshire's consistent buying and the company's strong fundamentals, investors should consider Constellation Brands (STZ) for its attractive valuation, durable market share, and robust free cash flow generation.
• For those with a higher risk tolerance, UnitedHealth (UNH) presents a contrarian opportunity, but requires close monitoring of its Medicare investigation and medical cost trends.
• Thematic investors could evaluate Nucor (NUE) as a derivative play on data center growth, with potential upside from protective steel tariffs.
• Observe the broader signal from Berkshire's $344 billion cash pile, which suggests maintaining a selective investment approach and caution regarding overall market valuations.